CN Patent

CN102908327B — 伊伐布雷定或其可药用盐的缓释制剂

Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2015-03-11 · 11y expired

What this patent protects

本发明涉及一种伊伐布雷定及其可药用盐的缓释制剂，其含有伊伐布雷定或其可药用盐和缓释骨架材料，所述缓释骨架材料选自聚氧乙烯、聚醋酸乙烯酯和聚乙烯吡咯烷酮聚合物中的一种或几种的混合物。本发明的伊伐布雷定及其可药用盐的缓释制剂可以降低血药浓度的峰谷现象，从而提高药物疗效、用药安全性，减少服药次数从而提高患者顺应性。

USPTO Abstract

本发明涉及一种伊伐布雷定及其可药用盐的缓释制剂，其含有伊伐布雷定或其可药用盐和缓释骨架材料，所述缓释骨架材料选自聚氧乙烯、聚醋酸乙烯酯和聚乙烯吡咯烷酮聚合物中的一种或几种的混合物。本发明的伊伐布雷定及其可药用盐的缓释制剂可以降低血药浓度的峰谷现象，从而提高药物疗效、用药安全性，减少服药次数从而提高患者顺应性。

Drugs covered by this patent

Patent Metadata

Patent number
CN102908327B
Jurisdiction
CN
Classification
—
Expires
2015-03-11
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hengrui Medicine Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.